Cipla Limited has informed the Exchange about press release dated 07-Sep-2022 titled Cipla receives USFDA approval for the generic version of Revlimid�� (Lenalidomide capsules)
Press Release Sep 07 2022
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Cipla
- Press Release Jul 29 2022
- Press Release Jul 14 2022
- Press Release Jun 27 2022
- Press Release Jun 17 2022
- Press Release Jun 14 2022
Later from Cipla
- Press Release Oct 11 2022
- Press Release Nov 04 2022
- Press Release Nov 29 2022
- Press Release Dec 30 2022
- Cipla Ltd Press Release Jan 18 2023
Follow Cipla into a list and get an email when it puts out news.
Follow Cipla